Cargando…

Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine

Detalles Bibliográficos
Autores principales:	Agharbi, F.-Z., Eljazouly, M., Basri, G., Faik, M., Benkirane, A., Albouzidi, A., Chiheb, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481089/ https://www.ncbi.nlm.nih.gov/pubmed/34686374 http://dx.doi.org/10.1016/j.annder.2021.07.008

Ejemplares similares

Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine()
por: Crespo Burillo, J.A., et al.
Publicado: (2021)

A Case Report of Exfoliative Bullous Rash Following AstraZeneca Vaccine
por: Saleem, Usman, et al.
Publicado: (2022)

Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine
por: Morlidge, Clare, et al.
Publicado: (2021)

Occlusive retinal vasculopathy following AstraZeneca COVID-19 vaccination: A case report
por: Werda, S., et al.
Publicado: (2023)

Lipschütz ulcers after AstraZeneca COVID-19 vaccination()
por: Bracho-Borro, Maria, et al.
Publicado: (2023)

Thrombotic events after AstraZeneca vaccine: What if it was related to dysfunctional immune response?
por: Billy, Eric, et al.
Publicado: (2021)

Granulomatous vasculitis after the AstraZeneca anti–SARS-CoV-2 vaccine
por: Gillion, Valentine, et al.
Publicado: (2021)

Paroxysmal supra-ventricular ventricular tachycardia after AstraZeneca COVID-19 vaccine injection
por: Lin, Y.-T., et al.
Publicado: (2022)

AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021)

Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
Publicado: (2021)

Vaccin Oxford/AstraZeneca, mode d’emploi
por: Dalmat, Yann-Mickael
Publicado: (2021)

Oxford–AstraZeneca COVID-19 vaccine efficacy
por: Knoll, Maria Deloria, et al.
Publicado: (2021)

AstraZeneca COVID-19 vaccine-related thromboembolism
Publicado: (2021)

Bleeding and clotting with AstraZeneca's COVID-19 vaccine
Publicado: (2021)

Imaging of Oxford/AstraZeneca® COVID-19 vaccine-induced immune thrombotic thrombocytopenia
por: Garnier, Matthieu, et al.
Publicado: (2021)

Ischemic stroke after AstraZeneca (Covid-19) vaccination
por: Alammar, Muath A.
Publicado: (2021)

[Translated article] Lipschütz Ulcers After the AstraZeneca COVID-19 Vaccine
por: González-Romero, N., et al.
Publicado: (2022)

Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines
por: Mahallawi, Waleed H., et al.
Publicado: (2021)

Psoriatic flare following Oxford-AstraZeneca ChAdOx1 COVID-19 and influenza vaccines
por: Teh, Natalie, et al.
Publicado: (2021)

AstraZeneca COVID-19 vaccine: no increased rate of VTE
Publicado: (2021)

No increased risk of anaphylaxis with AstraZeneca COVID-19 vaccine
Publicado: (2021)

AstraZeneca COVID-19 vaccine-related thrombocytopenia and thrombosis
Publicado: (2021)

Canadian findings on AstraZeneca COVID-19 Vaccine and COVISHIELD
Publicado: (2021)

AstraZeneca COVID-19 vaccine recommended in ≥50s in Australia
Publicado: (2021)

Risk-benefit of AstraZeneca COVID-19 vaccination in Australia
Publicado: (2021)

Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis
por: Allen-Philbey, K., et al.
Publicado: (2021)

Acute Arterial Occlusion Following ChAdOx1 nCov-19 (Oxford–AstraZeneca) Vaccination
por: Ali, Azhar, et al.
Publicado: (2022)

Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine
por: Di Bona, Danilo, et al.
Publicado: (2022)

Health Canada: blood clots with AstraZeneca's COVID-19 vaccine
Publicado: (2021)

Denmark ceases roll out of AstraZeneca's COVID-19 vaccine
Publicado: (2021)

Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine
por: Clayton-Chubb, Daniel, et al.
Publicado: (2021)

Relapsed focal segmental glomerulosclerosis and severe acute kidney injury after Oxford-AstraZeneca (AZ) COVID-19 vaccine
por: Huang, Yu-Ting, et al.
Publicado: (2022)

Erythema nodosum following the first dose of AstraZeneca COVID-19 vaccine
por: Berrim, K., et al.
Publicado: (2023)

Morbilliform Eruption After Administration of Second Dose of Oxford/AstraZeneca Vaccine
por: Alhammad, Norah S, et al.
Publicado: (2022)

Neuralgia amiotrófica secundaria a vacuna contra COVID-19 Vaxzevria (AstraZeneca)
por: Crespo Burillo, J.A., et al.
Publicado: (2021)

Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: A missed opportunity for a rapid return of experience
por: Geeraerts, Thomas, et al.
Publicado: (2021)

The impact of the AstraZeneca suspensions on the public’s vaccination intentions and trust: Marion de Vries
por: de Vries, M, et al.
Publicado: (2022)

Benefits of COVID-19 Vaccine AstraZeneca outweigh risks of blood clots
Publicado: (2021)

Thromboembolism and the Oxford–AstraZeneca COVID-19 vaccine: side-effect or coincidence?
por: Østergaard, Søren Dinesen, et al.
Publicado: (2021)

AstraZeneca COVID-19 vaccine not recommended in adults under 55 in Canada
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hkm3ara1t46fctsddnj3t4jgab